In the present study, the highest administered doses of BC (1 g/day/OVX; 1.5 g/day/ORX and 1.5 g/day/OVX; 2 g/day/ORX) triggered a higher local expression of the FGF2 gene in the tibia. Here, FGF2 is linked to breast cancer.